CNS Pharmaceuticals Q1 2026 Earnings EPS Misses Estimates Amid Ongoing Clinical Development Costs VPG Q1 2026 Earnings EPS Beats Estimates Despite Revenue Uncertainty Companhia Siderurgica Nacional SA SID Q1 2026 Earnings Deep EPS Miss but Stock Rallies on Operational Resilience Icahn Enterprises LP Q1 2026 Earnings Massive EPS Miss as Loss Exceeds Estimates OBIO Q1 2026 Earnings Loss Narrows More Than Expected Stock Modestly Declines MCRI Q1 2026 Earnings Strong EPS Beat Drives Positive Stock Reaction EYE Q1 2026 Earnings EPS Beats Estimates Stock Dips 3